nodes	percent_of_prediction	percent_of_DWPC	metapath
Tamibarotene—RARB—adrenal gland—polycystic ovary syndrome	0.0382	0.106	CbGeAlD
Tamibarotene—RARA—endometrium—polycystic ovary syndrome	0.0363	0.101	CbGeAlD
Tamibarotene—RARB—female gonad—polycystic ovary syndrome	0.0356	0.0991	CbGeAlD
Tamibarotene—RARB—vagina—polycystic ovary syndrome	0.0354	0.0985	CbGeAlD
Tamibarotene—RARA—uterus—polycystic ovary syndrome	0.0334	0.0929	CbGeAlD
Tamibarotene—RARB—endocrine gland—polycystic ovary syndrome	0.0331	0.0922	CbGeAlD
Tamibarotene—RARA—pituitary gland—polycystic ovary syndrome	0.0328	0.0912	CbGeAlD
Tamibarotene—RARA—adipose tissue—polycystic ovary syndrome	0.0327	0.0909	CbGeAlD
Tamibarotene—RARA—adrenal gland—polycystic ovary syndrome	0.0293	0.0815	CbGeAlD
Tamibarotene—RARA—female gonad—polycystic ovary syndrome	0.0273	0.076	CbGeAlD
Tamibarotene—RARA—endocrine gland—polycystic ovary syndrome	0.0254	0.0707	CbGeAlD
Tamibarotene—RARB—Vitamin A and Carotenoid Metabolism—RBP4—polycystic ovary syndrome	0.022	0.0344	CbGpPWpGaD
Tamibarotene—RARA—Vitamin A and Carotenoid Metabolism—RBP4—polycystic ovary syndrome	0.0211	0.0329	CbGpPWpGaD
Tamibarotene—RARA—Adipogenesis—LIFR—polycystic ovary syndrome	0.02	0.0312	CbGpPWpGaD
Tamibarotene—RARB—Nuclear Receptors—PGR—polycystic ovary syndrome	0.0198	0.0309	CbGpPWpGaD
Tamibarotene—RARA—Nuclear Receptors—PGR—polycystic ovary syndrome	0.019	0.0297	CbGpPWpGaD
Tamibarotene—RARA—Adipogenesis—RETN—polycystic ovary syndrome	0.0163	0.0255	CbGpPWpGaD
Tamibarotene—RARA—Adipogenesis—LIF—polycystic ovary syndrome	0.0163	0.0255	CbGpPWpGaD
Tamibarotene—RARB—Nuclear Receptor transcription pathway—PGR—polycystic ovary syndrome	0.0157	0.0244	CbGpPWpGaD
Tamibarotene—RARB—Nuclear Receptors—AR—polycystic ovary syndrome	0.0154	0.0241	CbGpPWpGaD
Tamibarotene—RARA—Nuclear Receptor transcription pathway—PGR—polycystic ovary syndrome	0.015	0.0234	CbGpPWpGaD
Tamibarotene—RARA—Nuclear Receptors—AR—polycystic ovary syndrome	0.0148	0.0231	CbGpPWpGaD
Tamibarotene—RARB—RXR and RAR heterodimerization with other nuclear receptor—PPARG—polycystic ovary syndrome	0.0131	0.0204	CbGpPWpGaD
Tamibarotene—RARA—RXR and RAR heterodimerization with other nuclear receptor—PPARG—polycystic ovary syndrome	0.0125	0.0196	CbGpPWpGaD
Tamibarotene—RARB—Nuclear Receptors—NR3C1—polycystic ovary syndrome	0.0125	0.0195	CbGpPWpGaD
Tamibarotene—RARB—Nuclear Receptor transcription pathway—AR—polycystic ovary syndrome	0.0122	0.019	CbGpPWpGaD
Tamibarotene—RARA—Nuclear Receptors—NR3C1—polycystic ovary syndrome	0.0119	0.0186	CbGpPWpGaD
Tamibarotene—RARB—Generic Transcription Pathway—ZNF205—polycystic ovary syndrome	0.0118	0.0185	CbGpPWpGaD
Tamibarotene—RARB—Generic Transcription Pathway—ZNF430—polycystic ovary syndrome	0.0118	0.0185	CbGpPWpGaD
Tamibarotene—RARA—Nuclear Receptor transcription pathway—AR—polycystic ovary syndrome	0.0117	0.0182	CbGpPWpGaD
Tamibarotene—RARA—Generic Transcription Pathway—ZNF430—polycystic ovary syndrome	0.0113	0.0177	CbGpPWpGaD
Tamibarotene—RARA—Generic Transcription Pathway—ZNF205—polycystic ovary syndrome	0.0113	0.0177	CbGpPWpGaD
Tamibarotene—RARB—RXR and RAR heterodimerization with other nuclear receptor—BCL2—polycystic ovary syndrome	0.0108	0.0169	CbGpPWpGaD
Tamibarotene—RARB—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—polycystic ovary syndrome	0.0105	0.0165	CbGpPWpGaD
Tamibarotene—RARA—RXR and RAR heterodimerization with other nuclear receptor—BCL2—polycystic ovary syndrome	0.0104	0.0162	CbGpPWpGaD
Tamibarotene—RARA—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—polycystic ovary syndrome	0.0101	0.0158	CbGpPWpGaD
Tamibarotene—RARB—Nuclear Receptor transcription pathway—NR3C1—polycystic ovary syndrome	0.00984	0.0154	CbGpPWpGaD
Tamibarotene—RARB—Nuclear Receptors—PPARG—polycystic ovary syndrome	0.00965	0.0151	CbGpPWpGaD
Tamibarotene—RARA—Nuclear Receptor transcription pathway—NR3C1—polycystic ovary syndrome	0.00944	0.0147	CbGpPWpGaD
Tamibarotene—RARA—Nuclear Receptors—PPARG—polycystic ovary syndrome	0.00925	0.0144	CbGpPWpGaD
Tamibarotene—RARB—Integrated Pancreatic Cancer Pathway—FST—polycystic ovary syndrome	0.00785	0.0123	CbGpPWpGaD
Tamibarotene—RARA—Adipogenesis—NAMPT—polycystic ovary syndrome	0.00781	0.0122	CbGpPWpGaD
Tamibarotene—RARB—Nuclear Receptor transcription pathway—PPARG—polycystic ovary syndrome	0.00762	0.0119	CbGpPWpGaD
Tamibarotene—RARA—Integrated Pancreatic Cancer Pathway—FST—polycystic ovary syndrome	0.00753	0.0118	CbGpPWpGaD
Tamibarotene—RARA—Adipogenesis—LMNA—polycystic ovary syndrome	0.0074	0.0116	CbGpPWpGaD
Tamibarotene—RARA—Nuclear Receptor transcription pathway—PPARG—polycystic ovary syndrome	0.00731	0.0114	CbGpPWpGaD
Tamibarotene—RARB—Generic Transcription Pathway—TEAD2—polycystic ovary syndrome	0.00648	0.0101	CbGpPWpGaD
Tamibarotene—RARA—Adipogenesis—ADIPOQ—polycystic ovary syndrome	0.00639	0.00998	CbGpPWpGaD
Tamibarotene—RARA—Generic Transcription Pathway—TEAD2—polycystic ovary syndrome	0.00621	0.0097	CbGpPWpGaD
Tamibarotene—RARA—Adipogenesis—SLC2A4—polycystic ovary syndrome	0.00604	0.00942	CbGpPWpGaD
Tamibarotene—RARB—Gene Expression—ZNF205—polycystic ovary syndrome	0.00569	0.00889	CbGpPWpGaD
Tamibarotene—RARB—Gene Expression—ZNF430—polycystic ovary syndrome	0.00569	0.00889	CbGpPWpGaD
Tamibarotene—RARA—Gene Expression—ZNF205—polycystic ovary syndrome	0.00546	0.00852	CbGpPWpGaD
Tamibarotene—RARA—Gene Expression—ZNF430—polycystic ovary syndrome	0.00546	0.00852	CbGpPWpGaD
Tamibarotene—RARB—Integrated Pancreatic Cancer Pathway—TOP2A—polycystic ovary syndrome	0.00544	0.0085	CbGpPWpGaD
Tamibarotene—RARA—Integrated Pancreatic Cancer Pathway—TOP2A—polycystic ovary syndrome	0.00522	0.00815	CbGpPWpGaD
Tamibarotene—RARB—Gene Expression—ADARB1—polycystic ovary syndrome	0.00484	0.00756	CbGpPWpGaD
Tamibarotene—RARA—Adipogenesis—NCOR1—polycystic ovary syndrome	0.00483	0.00753	CbGpPWpGaD
Tamibarotene—RARA—Gene Expression—ADARB1—polycystic ovary syndrome	0.00464	0.00725	CbGpPWpGaD
Tamibarotene—RARA—Adipogenesis—NR3C1—polycystic ovary syndrome	0.00446	0.00697	CbGpPWpGaD
Tamibarotene—RARB—Integrated Pancreatic Cancer Pathway—AR—polycystic ovary syndrome	0.00423	0.00661	CbGpPWpGaD
Tamibarotene—RARA—Integrated Pancreatic Cancer Pathway—AR—polycystic ovary syndrome	0.00406	0.00634	CbGpPWpGaD
Tamibarotene—RARA—Adipogenesis—IRS2—polycystic ovary syndrome	0.00406	0.00633	CbGpPWpGaD
Tamibarotene—RARA—Adipogenesis—LEP—polycystic ovary syndrome	0.00397	0.0062	CbGpPWpGaD
Tamibarotene—RARB—Gene Expression—LSM5—polycystic ovary syndrome	0.00395	0.00616	CbGpPWpGaD
Tamibarotene—RARA—Gene Expression—LSM5—polycystic ovary syndrome	0.00378	0.00591	CbGpPWpGaD
Tamibarotene—RARB—Gene Expression—SAP30L—polycystic ovary syndrome	0.00367	0.00573	CbGpPWpGaD
Tamibarotene—RARB—Integrated Pancreatic Cancer Pathway—BAX—polycystic ovary syndrome	0.00361	0.00563	CbGpPWpGaD
Tamibarotene—RARA—Adipogenesis—IRS1—polycystic ovary syndrome	0.00354	0.00553	CbGpPWpGaD
Tamibarotene—RARA—Gene Expression—SAP30L—polycystic ovary syndrome	0.00352	0.00549	CbGpPWpGaD
Tamibarotene—RARA—Adipogenesis—PPARG—polycystic ovary syndrome	0.00346	0.0054	CbGpPWpGaD
Tamibarotene—RARA—Integrated Pancreatic Cancer Pathway—BAX—polycystic ovary syndrome	0.00346	0.0054	CbGpPWpGaD
Tamibarotene—RARA—Adipogenesis—INS—polycystic ovary syndrome	0.00339	0.0053	CbGpPWpGaD
Tamibarotene—RARA—Adipogenesis—IGF1—polycystic ovary syndrome	0.00328	0.00512	CbGpPWpGaD
Tamibarotene—RARB—Gene Expression—TEAD2—polycystic ovary syndrome	0.00312	0.00487	CbGpPWpGaD
Tamibarotene—RARA—Adipogenesis—SERPINE1—polycystic ovary syndrome	0.00312	0.00486	CbGpPWpGaD
Tamibarotene—RARB—Generic Transcription Pathway—YAP1—polycystic ovary syndrome	0.0031	0.00483	CbGpPWpGaD
Tamibarotene—RARA—Gene Expression—TEAD2—polycystic ovary syndrome	0.00299	0.00467	CbGpPWpGaD
Tamibarotene—RARA—Generic Transcription Pathway—YAP1—polycystic ovary syndrome	0.00297	0.00464	CbGpPWpGaD
Tamibarotene—RARB—Generic Transcription Pathway—PGR—polycystic ovary syndrome	0.0027	0.00422	CbGpPWpGaD
Tamibarotene—RARA—Generic Transcription Pathway—PGR—polycystic ovary syndrome	0.00259	0.00405	CbGpPWpGaD
Tamibarotene—RARB—Integrated Pancreatic Cancer Pathway—IGF1—polycystic ovary syndrome	0.00252	0.00393	CbGpPWpGaD
Tamibarotene—RARA—Integrated Pancreatic Cancer Pathway—IGF1—polycystic ovary syndrome	0.00241	0.00377	CbGpPWpGaD
Tamibarotene—RARB—Gene Expression—RPL37A—polycystic ovary syndrome	0.00222	0.00347	CbGpPWpGaD
Tamibarotene—RARB—Integrated Pancreatic Cancer Pathway—BCL2—polycystic ovary syndrome	0.0022	0.00343	CbGpPWpGaD
Tamibarotene—RARA—Gene Expression—RPL37A—polycystic ovary syndrome	0.00213	0.00333	CbGpPWpGaD
Tamibarotene—RARA—Integrated Pancreatic Cancer Pathway—BCL2—polycystic ovary syndrome	0.0021	0.00329	CbGpPWpGaD
Tamibarotene—RARB—Generic Transcription Pathway—AR—polycystic ovary syndrome	0.0021	0.00328	CbGpPWpGaD
Tamibarotene—RARA—Generic Transcription Pathway—AR—polycystic ovary syndrome	0.00202	0.00315	CbGpPWpGaD
Tamibarotene—RARB—Generic Transcription Pathway—NCOR1—polycystic ovary syndrome	0.00184	0.00287	CbGpPWpGaD
Tamibarotene—RARA—Generic Transcription Pathway—NCOR1—polycystic ovary syndrome	0.00176	0.00275	CbGpPWpGaD
Tamibarotene—RARB—Generic Transcription Pathway—NR3C1—polycystic ovary syndrome	0.0017	0.00266	CbGpPWpGaD
Tamibarotene—RARB—Integrated Pancreatic Cancer Pathway—VEGFA—polycystic ovary syndrome	0.00164	0.00257	CbGpPWpGaD
Tamibarotene—RARA—Generic Transcription Pathway—NR3C1—polycystic ovary syndrome	0.00163	0.00255	CbGpPWpGaD
Tamibarotene—RARA—Integrated Pancreatic Cancer Pathway—VEGFA—polycystic ovary syndrome	0.00158	0.00246	CbGpPWpGaD
Tamibarotene—RARB—Gene Expression—YAP1—polycystic ovary syndrome	0.00149	0.00233	CbGpPWpGaD
Tamibarotene—RARA—Adipogenesis—IL6—polycystic ovary syndrome	0.00148	0.00231	CbGpPWpGaD
Tamibarotene—RARA—Gene Expression—YAP1—polycystic ovary syndrome	0.00143	0.00223	CbGpPWpGaD
Tamibarotene—RARB—Generic Transcription Pathway—PPARG—polycystic ovary syndrome	0.00132	0.00206	CbGpPWpGaD
Tamibarotene—RARB—Gene Expression—TNRC6B—polycystic ovary syndrome	0.00131	0.00205	CbGpPWpGaD
Tamibarotene—RARB—Gene Expression—PGR—polycystic ovary syndrome	0.0013	0.00203	CbGpPWpGaD
Tamibarotene—RARA—Generic Transcription Pathway—PPARG—polycystic ovary syndrome	0.00126	0.00197	CbGpPWpGaD
Tamibarotene—RARA—Gene Expression—TNRC6B—polycystic ovary syndrome	0.00126	0.00197	CbGpPWpGaD
Tamibarotene—RARA—Gene Expression—PGR—polycystic ovary syndrome	0.00125	0.00195	CbGpPWpGaD
Tamibarotene—RARB—Generic Transcription Pathway—SERPINE1—polycystic ovary syndrome	0.00119	0.00185	CbGpPWpGaD
Tamibarotene—RARA—Generic Transcription Pathway—SERPINE1—polycystic ovary syndrome	0.00114	0.00178	CbGpPWpGaD
Tamibarotene—RARB—Gene Expression—AR—polycystic ovary syndrome	0.00101	0.00158	CbGpPWpGaD
Tamibarotene—RARA—Gene Expression—AR—polycystic ovary syndrome	0.00097	0.00152	CbGpPWpGaD
Tamibarotene—RARB—Gene Expression—NCOR1—polycystic ovary syndrome	0.000885	0.00138	CbGpPWpGaD
Tamibarotene—RARA—Gene Expression—NCOR1—polycystic ovary syndrome	0.000848	0.00132	CbGpPWpGaD
Tamibarotene—RARB—Gene Expression—NR3C1—polycystic ovary syndrome	0.000819	0.00128	CbGpPWpGaD
Tamibarotene—RARA—Gene Expression—NR3C1—polycystic ovary syndrome	0.000785	0.00123	CbGpPWpGaD
Tamibarotene—RARB—Gene Expression—PPARG—polycystic ovary syndrome	0.000634	0.00099	CbGpPWpGaD
Tamibarotene—RARA—Gene Expression—PPARG—polycystic ovary syndrome	0.000608	0.000949	CbGpPWpGaD
Tamibarotene—RARB—Gene Expression—SERPINE1—polycystic ovary syndrome	0.000571	0.000892	CbGpPWpGaD
Tamibarotene—RARA—Gene Expression—SERPINE1—polycystic ovary syndrome	0.000548	0.000855	CbGpPWpGaD
